India has deep strengths in reverse engineering and API development, while Russia has strong capabilities in certain vaccines, biologicals, and niche therapeutic segments. Collaboration can significantly shorten R&D timelines
Agreements mark a major victory in the President’s long-term pledge to lower prescription drug costs for Americans
This latest commitment brings the British pharmaceutical company’s total investment at the site to $886 million
The discussions come as part of the administration’s broader efforts to drive down drug prices and increase patient access to essential therapies
Capvaxive has recorded $530 million in cumulative sales over its first four quarters on the market
The Court dismissed Swiss drugmaker Roche’s plea for interim injunction
Max and Luna personify HRV Pharma’s core values of trust, loyalty, and authentic partnership
This agreement grants Vizient clients enhanced access to Natrelle, the broadest selection of breast implant options on the market
Pfizer will participate in TrumpRx.gov, a direct-to-patient purchasing platform offering discount up to 85%
The platform is being introduced to expand access to treatments for people living with chronic conditions
Subscribe To Our Newsletter & Stay Updated
